T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
Veralto
VLTO
|
+$1.54B |
| 2 |
Lattice Semiconductor
LSCC
|
+$380M |
| 3 |
Canadian Natural Resources
CNQ
|
+$333M |
| 4 |
Intuit
INTU
|
+$306M |
| 5 |
TechnipFMC
FTI
|
+$301M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
+$1.16B |
| 2 |
Texas Instruments
TXN
|
+$639M |
| 3 |
Equifax
EFX
|
+$567M |
| 4 |
TransUnion
TRU
|
+$460M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$454M |
Sector Composition
| 1 | Technology | 22.55% |
| 2 | Healthcare | 20.34% |
| 3 | Industrials | 12.93% |
| 4 | Consumer Discretionary | 12.23% |
| 5 | Financials | 12.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Crinetics Pharmaceuticals
CRNX
$3.44B
| $86M | 0.06% |
2,417,493
+776,801
| +47% | +$27.6M |
|
302
ASGN Inc
ASGN
$2.29B
| $85.6M | 0.06% |
889,908
+503,320
| +130% | +$48.4M |
|
303
Mueller Water Products
MWA
$3.85B
| $85.2M | 0.06% |
5,916,437
+17,460
| +0.3% | +$251K |
|
304
Arcosa
ACA
$4.69B
| $84.4M | 0.05% |
+1,021,509
| New | +$84.4M |
|
305
Pure Storage
PSTG
$25.9B
| $84.2M | 0.05% |
2,359,869
+2,182,559
| +1,231% | +$77.8M |
|
|
BFS
306
Saul Centers
BFS
$792M
| $84.1M | 0.05% |
2,141,415
+3,059
| +0.1% | +$120K |
|
307
Dorman Products
DORM
$4.98B
| $83.6M | 0.05% |
1,001,862
+7,294
| +0.7% | +$608K |
|
308
WillScot Mobile Mini Holdings
WSC
$4.16B
| $83.5M | 0.05% |
1,875,623
+1,117,391
| +147% | +$49.7M |
|
|
HAYN
309
DELISTED
Haynes International, Inc.
HAYN
| $83.4M | 0.05% |
1,462,294
-1,360
| -0.1% | -$77.6K |
|
310
Liberty Live Group Series C
LLYVK
$9.21B
| $83.1M | 0.05% |
2,223,732
+72,607
| +3% | +$2.71M |
|
311
PotlatchDeltic
PCH
$3.22B
| $82.8M | 0.05% |
1,686,898
-169,527
| -9% | -$8.32M |
|
312
BILL Holdings
BILL
$5.17B
| $82.8M | 0.05% |
1,014,728
-1,520,862
| -60% | -$124M |
|
313
Permian Resources
PR
$9.66B
| $82.6M | 0.05% |
6,075,535
+3,960,055
| +187% | +$53.9M |
|
|
ENV
314
DELISTED
ENVESTNET, INC.
ENV
| $82.1M | 0.05% |
1,657,619
-58,649
| -3% | -$2.9M |
|
315
Orion
OEC
$589M
| $80.9M | 0.05% |
2,916,310
+35,828
| +1% | +$994K |
|
316
Vaxcyte
PCVX
$4.25B
| $78.3M | 0.05% |
1,246,041
+41,413
| +3% | +$2.6M |
|
317
Enpro
NPO
$4.52B
| $78.1M | 0.05% |
498,302
-1,432
| -0.3% | -$224K |
|
318
Shoals Technologies Group
SHLS
$1.11B
| $78M | 0.05% |
5,021,078
| – | – |
|
319
Humana
HUM
$32.8B
| $78M | 0.05% |
170,435
-727,649
| -81% | -$333M |
|
320
Pacific Biosciences
PACB
$393M
| $76.1M | 0.05% |
7,753,781
+338,257
| +5% | +$3.32M |
|
321
Voya Financial
VOYA
$7.28B
| $75.6M | 0.05% |
1,036,219
+70,626
| +7% | +$5.15M |
|
322
Coca-Cola Consolidated
COKE
$10.7B
| $75.4M | 0.05% |
811,640
-1,069,810
| -57% | -$99.3M |
|
323
Kohl's
KSS
$1.86B
| $74.7M | 0.05% |
2,604,855
+9,607
| +0.4% | +$276K |
|
|
CHUY
324
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $73.7M | 0.05% |
1,928,818
-120,336
| -6% | -$4.6M |
|
325
MoonLake Immunotherapeutics
MLTX
$3.62B
| $73.7M | 0.05% |
1,220,602
+5,879
| +0.5% | +$355K |
|